Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Knight will lead on the strategic development of the NIHR’s infrastructure, working in partnership with infrastructure leaders.

Marian Knight

Professor Marian Knight, who is Professor of Maternal and Child Population Health and Director of the National Perinatal Epidemiology Unit at Oxford Population Health, has been appointed National Institute for Health and Care Research (NIHR) Scientific Director for Research Infrastructure. Professor Knight is one of four scientific directors to be appointed to the new NIHR Board.

Professor Knight will lead on the strategic development of the NIHR’s infrastructure, working in partnership with infrastructure leaders. As part of her role on the NIHR Board, Professor Knight will support the Department of Health and Social Care Chief Scientific Advisor and NIHR Chief Executive, and the Director of Science Research and Evidence to deliver against the NIHR’s mission to improve the health and wealth of the national through research.

Professor Knight said, ‘I am delighted to have been appointed as an NIHR scientific director. I am looking forward to leading the strategic development of research infrastructure to enable advancements in science that will transform health and care in the UK and improve outcomes for patients and the public. Working in collaboration with the directors of the Biomedical Research Centres, Translational Research Collaborations, Applied Research Collaborations, the Research Support Service and other parts of NIHR infrastructure, this role is a fantastic opportunity to further boost the impact of health and care research in the UK.’

Read the full story on the Nuffield Department of Population Health website. 

Similar stories

First clinical study in GSK-Oxford Experimental Medicine Collaboration starts as first patient dosed in ulcerative colitis experimental trial

The first patient in the PEGASUS clinical study, part of the GSK-University of Oxford Experimental Medicine Collaboration, received the first dose last week, on 8 October 2026.

Wearable chest patch could support hospital-level care at home, study finds

Researchers in Oxford have shown that wearable chest patches can be used to effectively monitor vital signs in many acutely unwell patients receiving hospital-level care in their own homes.

Brain immune cells protect neurons in Parkinson’s disease by “nibbling” harmful material

New research, published in Science Translational Medicine, reveals how a specialised population of the brain’s immune cells can remove harmful protein clumps from nerve cells (neurons), pointing to potential new treatments for Parkinson’s disease.

Phase I clinical study of ChAdOx1 BDBV vaccine launches in Uganda

The Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine (MRC/UVRI & LSHTM Uganda Research Unit) has launched a Phase I clinical study evaluating the safety and immunogenicity of a candidate vaccine against Bundibugyo virus disease (BVD), a severe form of Ebola virus disease caused by Bundibugyo virus (BDBV), in partnership with the University of Oxford.

The Nuffield Department of Women's & Reproductive Health's Clinical Research Group recruits its 2,000th participant to the Generation Study

Oxford’s Clinical Research Group (CRG) has reached an important milestone after recruiting its 2,000th participant to the nationwide Generation Study.

Dementias Platform UK (DPUK) blood biomarker project takes next step towards NHS dementia diagnosis

A project involving researchers from the Universities of Oxford and Cambridge, Imperial College London and Dementias Platform UK (DPUK) has been selected for a major UK initiative aimed at improving dementia diagnosis and helping more people access the support and treatment they need sooner.